Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q59121335 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241221010729.0 | ||
008 | 241221nneanz||abbn n and d | ||
035 | ‡a (WKP)Q59121335 | ||
024 | ‡a 0000-0003-3055-914X ‡2 orcid | ||
024 | ‡a 56134220400 ‡2 scopus | ||
035 | ‡a (OCoLC)Q59121335 | ||
043 | ‡c PT | ||
100 | 0 | ‡a Sandra Tavares ‡c investigadora portuguesa em Biologia Integrativa e Biomedicina ‡9 pt | |
375 | ‡a 2 ‡2 iso5218 | ||
400 | 0 | ‡a Sandra Tavares ‡c Portuguese researcher in integrative biology and biomedicine ‡9 en | |
400 | 0 | ‡a S Tavares ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's Actin stress fiber organization promotes cell stiffening and proliferation of pre-invasive breast cancer cells | ||
670 | ‡a Author's Degradation pathway of pentachlorophenol by Mucor plumbeus involves phase II conjugation and oxidation-reduction reactions. | ||
670 | ‡a Author's GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells. | ||
670 | ‡a Author's The response of Mucor plumbeus to pentachlorophenol: a toxicoproteomics study. | ||
909 | ‡a (scopus) 56134220400 ‡9 1 | ||
909 | ‡a (orcid) 000000033055914x ‡9 1 | ||
919 | ‡a degradationpathwayofpentachlorophenolbymucorplumbeusinvolvesphase2conjugationandoxidationreductionreactions ‡A Degradation pathway of pentachlorophenol by Mucor plumbeus involves phase II conjugation and oxidation-reduction reactions. ‡9 1 | ||
919 | ‡a actinstressfiberorganizationpromotescellstiffeningandproliferationofpreinvasivebreastcancercells ‡A Actin stress fiber organization promotes cell stiffening and proliferation of pre-invasive breast cancer cells ‡9 1 | ||
919 | ‡a responseofmucorplumbeustopentachlorophenolatoxicoproteomicsstudy ‡A The response of Mucor plumbeus to pentachlorophenol: a toxicoproteomics study. ‡9 1 | ||
919 | ‡a gnaqandbrafmutationsshowdifferentialactivationofthemtorpathwayinhumantransformedcells ‡A GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells. ‡9 1 | ||
946 | ‡a a ‡9 1 | ||
947 | ‡a PT ‡9 1 | ||
996 | ‡2 DNB|1074952766 | ||
996 | ‡2 PTBNP|1184899 | ||
996 | ‡2 ISNI|000000006743084X | ||
996 | ‡2 BLBNB|001481404 | ||
996 | ‡2 PTBNP|1369815 | ||
996 | ‡2 ISNI|0000000102580887 | ||
996 | ‡2 NKC|jo2017962244 | ||
996 | ‡2 SUDOC|149956002 | ||
996 | ‡2 RERO|A003889564 | ||
996 | ‡2 ISNI|0000000355927172 | ||
996 | ‡2 PLWABN|9812831441505606 | ||
996 | ‡2 PTBNP|1620252 | ||
996 | ‡2 BLBNB|000270458 | ||
996 | ‡2 DNB|173910394 | ||
996 | ‡2 PLWABN|9810661466005606 | ||
996 | ‡2 PTBNP|1420006 | ||
996 | ‡2 PTBNP|286679 | ||
996 | ‡2 PTBNP|1681791 | ||
996 | ‡2 ISNI|0000000070132026 | ||
996 | ‡2 LC|n 50008197 | ||
996 | ‡2 BNF|16615882 | ||
996 | ‡2 NUKAT|n 2018290629 | ||
996 | ‡2 RERO|A003538873 | ||
996 | ‡2 PTBNP|1399211 | ||
996 | ‡2 PTBNP|1854989 | ||
996 | ‡2 BNF|17779573 | ||
996 | ‡2 PTBNP|1930099 | ||
996 | ‡2 LC|no2018139808 | ||
996 | ‡2 LC|no2022127150 | ||
996 | ‡2 BLBNB|001453758 | ||
996 | ‡2 LIH|LNB:B_m_K_b_;=B_s_ | ||
996 | ‡2 PTBNP|81629 | ||
996 | ‡2 PTBNP|1584121 | ||
996 | ‡2 ISNI|0000000068784076 | ||
996 | ‡2 ISNI|0000000078352111 | ||
996 | ‡2 ISNI|0000000070413370 | ||
996 | ‡2 PTBNP|1608768 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |